Follow
Susan Swindells
Susan Swindells
Verified email at unmc.edu
Title
Cited by
Cited by
Year
Prevention of HIV-1 infection with early antiretroviral therapy
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England journal of medicine 365 (6), 493-505, 2011
87152011
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
DL Paterson, S Swindells, J Mohr, M Brester, EN Vergis, C Squier, ...
Annals of internal medicine 133 (1), 21-30, 2000
44922000
Antiretroviral therapy for the prevention of HIV-1 transmission
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England Journal of Medicine 375 (9), 830-839, 2016
18062016
Maraviroc for previously treated patients with R5 HIV-1 infection
RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ...
New England Journal of Medicine 359 (14), 1429-1441, 2008
9062008
Class-sparing regimens for initial treatment of HIV-1 infection
SA Riddler, R Haubrich, AG DiRienzo, L Peeples, WG Powderly, ...
New England Journal of Medicine 358 (20), 2095-2106, 2008
8622008
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ...
New England Journal of Medicine 365 (16), 1482-1491, 2011
7252011
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ...
The Lancet infectious diseases 14 (4), 281-290, 2014
6282014
Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness
S Swindells, J Mohr, JC Justis, S Berman, C Squier, MM Wagener, ...
International journal of STD & AIDS 10 (6), 383-391, 1999
3901999
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin
HA Gelbard, HS Nottet, S Swindells, M Jett, KA Dzenko, P Genis, R White, ...
Journal of virology 68 (7), 4628-4635, 1994
3891994
Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression
S Swindells, JF Andrade-Villanueva, GJ Richmond, G Rizzardini, ...
New England Journal of Medicine 382 (12), 1112-1123, 2020
3692020
Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain.
HS Nottet, Y Persidsky, VG Sasseville, AN Nukuna, P Bock, QH Zhai, ...
Journal of immunology (Baltimore, Md.: 1950) 156 (3), 1284-1295, 1996
3651996
Adherence of human immunodeficiency virus—infected patients to antiretroviral therapy
N Singh, SM Berman, S Swindells, JC Justis, JA Mohr, C Squier, ...
Clinical infectious diseases 29 (4), 824-830, 1999
3561999
Four-month rifapentine regimens with or without moxifloxacin for tuberculosis
SE Dorman, P Nahid, EV Kurbatova, PPJ Phillips, K Bryant, KE Dooley, ...
New England Journal of Medicine 384 (18), 1705-1718, 2021
3352021
One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis
S Swindells, R Ramchandani, A Gupta, CA Benson, J Leon-Cruz, ...
New England Journal of Medicine 380 (11), 1001-1011, 2019
3072019
The neuropathogenesis of HIV-1 infection
HE Gendelman, SA Lipton, M Tardieu, MI Bukrinsky, HSLM Nottet
Journal of Leucocyte Biology 56 (3), 389-398, 1994
3021994
Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA
AM Gross, PA Jaeger, JF Kreisberg, K Licon, KL Jepsen, M Khosroheidari, ...
Molecular cell 62 (2), 157-168, 2016
2892016
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
MG Peters, J Andersen, P Lynch, T Liu, B Alston‐Smith, CL Brosgart, ...
Hepatology 44 (5), 1110-1116, 2006
2472006
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non …
ET Overton, G Richmond, G Rizzardini, H Jaeger, C Orrell, F Nagimova, ...
The Lancet 396 (10267), 1994-2005, 2020
2312020
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
DA Wohl, G McComsey, P Tebas, TT Brown, MJ Glesby, D Reeds, ...
Clinical Infectious Diseases 43 (5), 645-653, 2006
2112006
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority …
JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ...
The lancet HIV 5 (5), e211-e220, 2018
2072018
The system can't perform the operation now. Try again later.
Articles 1–20